COVID-19 vaccine challenges: What have we learned so far and what remains to be done?

Rebecca Forman; Soleil Shah; Patrick P.T. Jeurissen; Mark Jit; Elias Mossialos

doi:https://doi.org/10.1016/j.healthpol.2021.03.013

doi.org/10.1016/j.healthpol.2021.03.013

COVID-19 vaccine challenges: What have we learned so far and what remains to be done?

,

,

..., Elias Mossialos

48

Health Policy

Volume: 125, Issue: 5, Pages: 553 - 567

Published: May 1, 2021

Abstract

Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine has garnered immense global interest. Less than a year after COVID-19 was declared a pandemic, several vaccine candidates had received emergency use authorization across a range of countries. Despite this scientific breakthrough, the journey from vaccine discovery to global herd immunity against COVID-19 continues to present significant policy challenges that require...